Atrys Health, S.A. (BME: ATRY)

Market Cap	240.72M
Revenue (ttm)	211.11M
Net Income (ttm)	-39.07M
Shares Out	75.94M
EPS (ttm)	-0.51
PE Ratio	n/a
Forward PE	121.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,324
Open	3.120
Previous Close	3.130
Day's Range	3.120 - 3.150
52-Week Range	2.770 - 4.480
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,061
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2023, Atrys Health's revenue was 206.10 million, an increase of 26.28% compared to the previous year's 163.20 million. Losses were -45.59 million, 97.0% more than in 2022.